Skip to content

Author

J. Gutkind

We have 2 of 620 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Aug 2026

mTOR inhibition augments antitumor immune effector response by reprogramming the TP53-mutant, immune-cold HNSCC tumor microenvironment

The findings demonstrate that mTORi with everolimus reverses multiple mechanisms of immune resistance and enhances anti-tumor T cell activity, and support mTORi as a rational therapeutic strategy for TP53-mutant HNSCC and for reprogramming the immune-resistant TME, particularly in patients who are likely to fail immuno...

Priyatosh Nath, Alok R. Khandelwal, Chun Li et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.